EMEA-002532-PIP01-18-M02
Key facts
| Active substance |
Phenobarbital
|
| Therapeutic area |
Neurology
|
| Decision number |
P/0301/2021
|
| PIP number |
EMEA-002532-PIP01-18-M02
|
| Pharmaceutical form(s) |
Oral suspension
|
| Condition(s) / indication(s) |
Treatment of epilepsy
|
| Route(s) of administration |
|
| Contact for public enquiries |
Proveca Pharma Limited
+44 (0)1614 682627 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|